Links for this Journal
The Therapeutic Potential for Catalytic Antibodies From a Concept to a Promise
pp. 125-132(8)
Authors:
Jone L.H.; WentworthJr P.
Links for this article
Leucine Aminopeptidase as a Target for Inhibitor Design
pp. 133-144(12)
Authors:
Grembecka J.; Kafarski P.
Links for this article
Therapeutic Applications of Sugar-Mimicking Glycosidase Inhibitors
pp. 145-154(10)
Authors:
Asano N.; Kato A.; Watson A.A.
Links for this article
Origin of Chiral Pharmacology Stereochemistry in Metalloprotease Inhibition
pp. 155-161(7)
Author:
Kim D.H.
Links for this article
Tacrine-Huperzine A Hybrids (Huprines) A New Class of Highly Potent and Selective Acetylcholinesterase Inhibitors of Interest for the Treatment of Alzheimer Disease
pp. 163-174(12)
Authors:
Camps P.; Munoz-Torrero D.
Links for this article
beta-Amyloid Aggregation Inhibitors for the Treatment of Alzheimer Disease Dream or Reality?
pp. 175-186(12)
Author:
Talaga P.
Links for this article
Quantitative Structure-Activity Relationship (QSAR) Paradigm - Hansch Era to New Millennium
pp. 187-195(9)
Author:
Debnath A.Kumar
Links for this article
Pharmaceutical Target Identification by Gene Expression Analysis
pp. 197-205(9)
Author:
Walker M.G.
Links for this article
Antihypertensive Drugs that Act on Renin-Angiotensin System with Emphasis in AT1 Antagonists
pp. 207-217(11)
Authors:
Mavromoustakos T.; Apostolopoulos V.; Matsoukas J.
Links for this article